AI for a task that should be done by a physician rather than using it for other burdens that are less worthy than expressing care for patients,” authors of an editorial wrote.

Results showed only 6 products had elevated levels of benzene and more than 90% of tested products had undetectable or extremely low levels of benzene. Certain over-the-counter (OTC) acne products ...

HealthDay News — Stopping glucagon-like peptide-1 receptor agonist (GLP-1 RA) treatment 14 days before total joint arthroplasty can minimize risks for complications, according to a study presented at ...

"The most effective health-promoting solution would be to effectively end food insecurity through social policies and an augmented social safety net." ...

The National Institutes of Health (NIH) is cutting or canceling more than 40 grants focused on vaccine hesitancy and ways to increase vaccine acceptance, accord ...

HealthDay News — The majority of people are unaware that the human papillomavirus (HPV) is more common among men and is associated with rising rates of cancers that directly impact men, according to ...

Vepdegestrant is a novel proteolysis targeting chimera protein degrader designed to target and degrade the estrogen receptor.

The Food and Drug Administration (FDA) has expanded the approval of Furoscix® (furosemide injection) to include the treatment of edema in patients with ...

The Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for SYD-101 (atropine sulfate) to slow the progression of ...

Years of research involving hundreds of thousands of children have found no link between autism and vaccines. HealthDay News — The US Centers for Disease Control and Prevention (CDC) is preparing to ...

Johnson & Johnson is ending the phase 3 VENTURA clinical development program evaluating aticaprant, a selective kappa receptor antagonist, as an adjunctive treatment for major depressive disorder (MDD ...

GLP-1 RA use linked to lower risks for myelodysplastic syndromes, myeloproliferative neoplasms compared with metformin ...